Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Sunshine Biopharma (SBFM) Cost of Revenue (2018 - 2025)

Sunshine Biopharma's Cost of Revenue history spans 8 years, with the latest figure at $5.5 million for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 133.1% year-over-year to $5.5 million; the TTM value through Dec 2025 reached $24.1 million, up 323.95%, while the annual FY2025 figure was $24.1 million, 2457.78% up from the prior year.
  • Cost of Revenue reached $5.5 million in Q4 2025 per SBFM's latest filing, down from $6.3 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $15.3 million in Q4 2023 to a low of -$16.8 million in Q4 2024.
  • Average Cost of Revenue over 5 years is $1.8 million, with a median of $207856.0 recorded in 2022.
  • Peak YoY movement for Cost of Revenue: crashed 640.39% in 2021, then skyrocketed 8482.28% in 2023.
  • A 5-year view of Cost of Revenue shows it stood at -$56541.0 in 2021, then skyrocketed by 414.28% to $177699.0 in 2022, then surged by 8482.28% to $15.3 million in 2023, then plummeted by 209.91% to -$16.8 million in 2024, then soared by 133.1% to $5.5 million in 2025.
  • Per Business Quant, the three most recent readings for SBFM's Cost of Revenue are $5.5 million (Q4 2025), $6.3 million (Q3 2025), and $6.0 million (Q2 2025).